OSCR in the 13F filings
Oscar Health Inc · CUSIP 687793109
- Quarter end
- 30 Jun 2024
- the date the book describes
- Filed
- 16 Sep 2024
- latest of these filings; the earliest 25 Jul 2024
- Managers listing it
- 12
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q1 2024 and Q2 2024; 10 listed it in both
- Shares listed
- 33,992,311
- combined, among listed positions
- Reported value
- $538m
- combined, at the quarter end
Among the 94 comparable managers: 6 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing OSCR in Q2 2024
12 of 12 holders
Largest increases and reductions, by shares
Increases
- Viking Global Investors LPexisting position · 5,928,038 shares now+1,196,036
- Renaissance Technologies LLCexisting position · 3,886,100 shares now+934,600
- Point72 Asset Management LPnew position · 930,238 shares now+930,238
- Holocene Advisors LPexisting position · 1,438,820 shares now+700,008
- Two Sigma Investments LPexisting position · 1,698,200 shares now+147,907
Reductions
- Southeastern Asset Management Incexisting position · 2,401,192 shares now-670,260
- Two Sigma Advisers LPexisting position · 1,313,500 shares now-200,100
New positions and exits
New (2)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 10 | $987m | n.a. | n.a. |
| Q2 2021 | 6 | $645m | n.a. | n.a. |
| Q3 2021 | 5 | $541m | n.a. | n.a. |
| Q4 2021 | 6 | $302m | n.a. | n.a. |
| Q1 2022 | 6 | $389m | n.a. | n.a. |
| Q2 2022 | 4 | $153m | n.a. | n.a. |
| Q3 2022 | 4 | $178m | n.a. | n.a. |
| Q4 2022 | 4 | $49m | n.a. | n.a. |
| Q1 2023 | 7 | $186m | n.a. | n.a. |
| Q2 2023 | 8 | $203m | n.a. | n.a. |
| Q3 2023 | 6 | $123m | n.a. | n.a. |
| Q4 2023 | 9 | $266m | 3 | 4 |
| Q1 2024 | 12 | $490m | 6 | 4 |
| Q2 2024 | 12 | $538m | 6 | 2 |
| Q3 2024 | 13 | $667m | 6 | 5 |
| Q4 2024 | 11 | $351m | 5 | 3 |
| Q1 2025 | 8 | $208m | 3 | 4 |
| Q2 2025 | 10 | $229m | 6 | 3 |
| Q3 2025 | 8 | $210m | 5 | 5 |
| Q4 2025 | 13 | $282m | 17 | 20 |
| Q1 2026 | 4 | $42m | 12 | 23 |
| Q2 2026 | 8 | $631m | 22 | 14 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
OSCR and UNH →OSCR and ELV →OSCR and CI →Choose a stock to compare with OSCR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own OSCR, latest filings →Back to the 13F Explorer →